Nineteen of the 48 cases (40%) presented a loss of at least one MMR (mismatch repair) protein and ten patients lost two markers (N = 7 for PMS2/MLH1, N = 2 for MSH6/MSH2, one tumor lost expression of all four proteins). Here, MSH6 is linked to neoplasm.